What are the Challenges in Developing Nanopharmaceuticals?
Despite their potential, nanopharmaceuticals face several challenges:
1. Toxicity: The long-term safety of nanoparticles is still under investigation. Some materials used in nanoparticles may be toxic to cells or tissues. 2. Regulatory Hurdles: Regulatory frameworks for nanopharmaceuticals are still evolving. Ensuring compliance with these regulations can be complex and costly. 3. Scalability: Manufacturing nanoparticles consistently and at a large scale remains a significant challenge. The processes involved are often complex and require stringent quality controls. 4. Stability: Nanoparticles can be unstable and may aggregate over time, which can affect their efficacy and safety.
